caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1538121421

Wudeneh ZewdieM.D.

NephrologyMidwest City, OKI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Wudeneh Zewdie's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 75 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
256601
OKLAHOMA HEART HOSPITAL, LLC2351,076
Bereket Alemu
Nephrology · Midwest City, OK
1692,065
Samson Ambaw
Nephrology · Midwest City, OK
1532,213
Oscar Falcon
Diagnostic Radiology · Oklahoma City, OK
133916
OLBERT, MARK112620
SSM HEALTH CARE OF OKLAHOMA, INC.110487
NPI 125533553579765
Asim Chohan
Cardiology · Midwest City, OK
72562
Emergency Medical Services Authority
Ambulance Service Provider · Oklahoma City, OK
70309
ANDREZIK, JOSEPH67414
Bart Rowlett
Diagnostic Radiology · Midwest City, OK
64285
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
5,719
Unique beneficiaries
—
Total services
9,030
Distinct HCPCS
27
Medicare payment
$353K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 85 Nephrology providers in OK — top quintile (cohort median 1,752).
PRESCRIBING · PART D · 2024
Total Rx claims
4,858
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
71
Brand share
22.4%
Top prescribed drugs
Calcitriol824 claims
Furosemide394 claims
Dapagliflozin Propanediol256 claims
Lisinopril253 claims
Potassium Chloride234 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
96.6
Cost
81.9
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$652
Payment records
29
By payment type
Food and Beverage$610
Education$42